Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00923
|
|||||
| Drug Name |
Tecadenoson
|
|||||
| Synonyms |
CVT-510; (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[[(3R)-oxolan-3-yl]amino]purin-9-yl]oxolane-3,4-diol; 204512-90-3; AC1L4KMO; Adenosine, N-(3R)-tetrahydro-3-furanyl)-; Adenosine, N-(3R)-tetrahydro-3-furanyl-; BDBM50138530; BDBM50224766; CHEMBL356254; CHEMBL392149; CS-0016174; CVT-510; D06019; DB04954; DTXSID80174415; GTPL5592; GZ1X96601Z; HY-19661; LS-190860; N-(3-Tetrahydrofuranyl)-6-aminopurine riboside; N6-[3-(R)-tetrahydrofuranyl]adenosine; SCHEMBL246787; Selenocompounds; Tecadenoson (USAN/INN); Tecadenoson [USAN:INN]; UNII-GZ1X96601Z
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Paroxysmal supraventricular tachycardia [ICD11: BC81.Z] | Discontinued in Phase 3 | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C14H19N5O5
|
|||||
| Canonical SMILES |
C1COCC1NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O
|
|||||
| InChI |
InChI=1S/C14H19N5O5/c20-3-8-10(21)11(22)14(24-8)19-6-17-9-12(15-5-16-13(9)19)18-7-1-2-23-4-7/h5-8,10-11,14,20-22H,1-4H2,(H,15,16,18)/t7-,8-,10-,11-,14-/m1/s1
|
|||||
| InChIKey |
OESBDSFYJMDRJY-BAYCTPFLSA-N
|
|||||
| CAS Number |
CAS 204512-90-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 337.33 | Topological Polar Surface Area | 135 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 9 | |||
| XLogP |
-0.3
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | ENT1 | Transporter Info | Equilibrative nucleoside transporter 1 | Substrate | [2] | |
| Drug-Transporter Activity Data | ||||||
| Drug-Transporter Activity Data | ENT1 | Transporter Info | Km = 24 microM | CCRF-CEM cells-ENT1 | [2] | |
| ENT1 | Transporter Info | Km = 196 microM | Oocytes-ENT1 | [2] | ||
| References | ||||||
| 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010504) | |||||
| 2 | Transport of A1 adenosine receptor agonist tecadenoson by human and mouse nucleoside transporters: evidence for blood-brain barrier transport by murine equilibrative nucleoside transporter 1 mENT1. Drug Metab Dispos. 2013 Apr;41(4):916-22. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.